TallyHQ
github
Client · LDA

ACADIA PHARMACEUTICALS

4 filings 13 bills mentioned 1 registrants 4 quarters ~$2,280,000 reported
Client ID
207583

Bills lobbied on

Bills referenced in this client's quarterly filings, ranked by filing count.

HR 1492
To amend title XI of the Social Security Act to equalize the negotiation period between small-molecule and biologic candidates under the Drug Price Negotiation Program.
HCRMMM
4
HR 946
ORPHAN Cures Act
HCRMMM
4
HR 1414
Cameron’s Law
HCRTAX
4
HR 1262
Mikaela Naylon Give Kids a Chance Act
HCR
4
S 1862
ORPHAN Cures Act
HCRMMM
3
S 752
Accelerating Kids’ Access to Care Act
HCRMMM
3
S 932
Give Kids a Chance Act of 2025
HCR
3
HR 3731
Small Biotech Innovation Act
HCR
3
HR 1
An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.
HCRMMMTAX
3
HR 1509
Accelerating Kids’ Access to Care Act of 2025
HCRMMM
3
S 1930
Small Biotech Innovation Act
HCR
3
S 832
EPIC Act of 2025
HCRMMM
3
—
119:hr:14114
TAX
1

Registrants

Lobbying firms that filed on behalf of this client.

ACADIA PHARMACEUTICALS 4

Source: Senate LDA quarterly filings (LD-2). Bill mentions extracted from free-text "specific issues" descriptions.